Edge Therapeutics, Inc. (Nasdaq: EDGE) announced the appointment of Daniel Brennan to the newly created position of Chief Operating Officer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE